Lovastatin and Vimpat drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lovastatin (lovastatin) and Vimpat (lacosamide). Common drug interactions include headache among females and memory impairment among males.

The phase IV clinical study analyzes what interactions people have when they take Lovastatin and Vimpat. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Lovastatin?

Lovastatin has active ingredients of lovastatin. It is often used in high blood cholesterol. eHealthMe is studying from 33,048 Lovastatin users. Check the latest studies of Lovastatin.

What is Vimpat?

Vimpat has active ingredients of lacosamide. It is often used in epilepsy. eHealthMe is studying from 20,831 Vimpat users. Check the latest studies of Vimpat.



On Jul, 02, 2026

33 people who take Lovastatin and Vimpat together, and have interactions are studied.

Lovastatin and Vimpat drug interactions.

What are the common drug interactions of Lovastatin and Vimpat, by gender? *:

female:

  1. Headache (pain in head)
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Fall
  4. Head injury
  5. Parkinsonism (degenerative disorder of the central nervous system characterized by tremor and impaired muscular coordination)
  6. Dyspnoea (difficult or laboured respiration)
  7. Nausea (feeling of having an urge to vomit)
  8. Anxiety
  9. Chest pain
  10. Disturbance in attention

male:

  1. Memory impairment
  2. Balance disorder
  3. Aggression
  4. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  5. Anxiety
  6. Body temperature increased
  7. Cataract (clouding of the lens inside the eye)
  8. Coma (state of unconsciousness lasting more than six hours)
  9. Confusional state
  10. Deafness

What are the common drug interactions of Lovastatin and Vimpat, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Asthenia (weakness)
  2. Diarrhoea
  3. Gastrostomy failure (failure of surgically made opening in stomach)
  4. Injection site pain
  5. Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract)
  6. Oral discomfort (pain or irritation in mouth)
  7. Pain in extremity
  8. Sedation
  9. Septic shock (shock due to blood infection)
  10. Somnolence (a state of near-sleep, a strong desire for sleep)

40-49:

  1. Acute myocardial infarction (acute heart attack)

50-59:

  1. Dehydration (dryness resulting from the removal of water)
  2. Drug ineffective
  3. Body temperature increased
  4. Coma (state of unconsciousness lasting more than six hours)
  5. Gout (uric acid crystals building up in the body)
  6. Memory impairment
  7. Nausea (feeling of having an urge to vomit)

60+:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Fall
  3. Hypersensitivity
  4. Pneumonia
  5. Contusion (a type of hematoma of tissue in which capillaries)
  6. Dyspnoea (difficult or laboured respiration)
  7. Feeling hot
  8. Frontal lobe epilepsy (recurring seizures that arise in the frontal lobes of the brain)
  9. Haematoma (collection of blood outside the blood vessels)
  10. Headache (pain in head)

What are the existing conditions these people have? *

  1. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 12 people, 36.36%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 15.15%
  3. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 15.15%
  4. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 4 people, 12.12%
  5. Depression: 4 people, 12.12%
  6. Gout (uric acid crystals building up in the body): 3 people, 9.09%
  7. Erection Problems: 3 people, 9.09%
  8. Blood Pressure Abnormal: 3 people, 9.09%
  9. Hypersensitivity: 3 people, 9.09%
  10. Dyspnea (difficult or laboured breathing): 3 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Lovastatin and Vimpat?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lovastatin and Vimpat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lovastatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vimpat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lovastatin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vimpat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lovastatin and lacosamide (the active ingredients of Lovastatin and Vimpat, respectively), and Lovastatin and Vimpat (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: